Monday, December 01, 2025 | 02:21 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

ICMR guideline spurs debate on regulation of stem cell banking

ICMR seeks to prevent commercialisation of unproven stem cell therapies; industry says move is detrimental as it will impede research in this sphere

Stem cell treatment. Representative image. Photo: Reuters
premium

Stem cell treatment. Photo: Reuters

Gireesh Babu Chennai
The Indian Council of Medical Research (ICMR) guideline on stem cell research has spurred the stem cell banking industry to discuss the need for regulations and guidelines on the storage of stem cells other than umbilical cord blood (UCB) cells. Currently, stem cell in general do not have substantial clinical benefits, but could be useful in future.

Major industry players in the segment say that at present there is lack of clarity about the collection and storage of these stem cells, which could be misused by some companies.

The National Guidelines for Stem Cell Research (NGSCR), 2017, which seeks to